← Back to Conditions

HNSHA due to glucose phosphate isomerase deficiency

disorder
SNOMED 52413004CUI C0272064

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Decreased glucose phosphate isomerase activity
Frequent (30-79%)HP:0003568
Enlarged liver
Frequent (30-79%)HP:0002240
Increased lactate dehydrogenase level
Frequent (30-79%)HP:0025435
Nonspherocytic hemolytic anaemia
Frequent (30-79%)HP:0001930
Reticulocytosis
Frequent (30-79%)HP:0001923
Unconjugated hyperbilirubinemia
Frequent (30-79%)HP:0008282
Yellowing of the skin
Frequent (30-79%)HP:0000952
Hydrops fetalis
Occasional (5-29%)HP:0001789
Mental deficiency
Occasional (5-29%)HP:0001249
Poikilocytosis
Occasional (5-29%)HP:0004447
Ataxia
HP:0001251
Gallbladder inflammation
HP:0001082
Gallstones
HP:0001081
Impaired neutrophil bactericidal activity
HP:0011993
Large spleen
HP:0001744
Muscle weakness
HP:0001324
Pigment gallstones
HP:0011981
Sensory ataxia
HP:0010871
Spontaneous hemolytic crises
HP:0005525

Quick Facts

SNOMED CT
52413004
UMLS CUI
C0272064
Fully Specified Name
Hereditary nonspherocytic hemolytic anemia due to glucose phosphate isomerase deficiency (disorder)
Specialists
0
Diagnostic Biomarkers
0
HPO Phenotypes
19
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.